1. Lawsuit-ridden J&J tumbles in annual listing of best global brands — AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC — Shionogi's antibiotic clears FDA panel vote — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

New drug?

Discussion in 'Promius Pharma' started by anonymous, Jan 29, 2019 at 12:48 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What's the scoop on Tosymra? See it's new and just got FDA approval. Anything worth noting?
     
  2. anonymous

    anonymous Guest

    That intranasal formulation of sumatriptan is amazing !!!

    It has some clever absorption enhancer - Intravail - that makes the intranasal as good as subcutaneous injections.

    My docs are raving about it.
    I tried to get my foot in the door of Promius, but too many applicants for the Chicago position.
    Too bad - is an easy drug to sell.
     
  3. anonymous

    anonymous Guest

    Wow! Can't wait to read the clinical studies that show data demonstrating that Intravail aids in absorption in the nasal cavity.
     
  4. anonymous

    anonymous Guest

    Yeah, could be interesting. Not like either intravail or sumatriptan haven't been around long enough. Good track record for each compound. Despite that, there's been enough weak contenders pushed for migraines that this may seem the same all over again.
     
  5. anonymous

    anonymous Guest

    is it just me or do the top 3 posts seem like they were written by someone in marketing
     
  6. anonymous

    anonymous Guest

    Immediately thought the same thing
     
  7. anonymous

    anonymous Guest

    Same. Nice try!
     
  8. anonymous

    anonymous Guest

    Does anyone know when it will be available?
     
  9. anonymous

    anonymous Guest

    Crickets